Christopher Guttman-McCabe, Chief Regulatory and Corporate Communications Officer, on June 15, 2026, sold 91,437 shares in Anterix (ATEX) for $7,539,884. Following the Form 4 filing with the SEC, Guttman-McCabe has control over a total of 77,807 common shares of the company, with 77,807 shares held directly.
SEC Filing: